ProfileGDS4718 / 1553138_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 17% 16% 14% 20% 13% 13% 11% 21% 13% 20% 16% 13% 11% 14% 7% 20% 17% 13% 7% 9% 19% 19% 22% 24% 16% 12% 13% 10% 25% 7% 10% 4% 15% 19% 9% 9% 12% 13% 16% 15% 21% 7% 7% 43% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0387917
GSM549102patient 115, normal, homogenized [OPG study]4.0236616
GSM549104patient 119, normal, homogenized [OPG study]3.8875414
GSM549108patient 138, normal, homogenized [OPG study]4.1741220
GSM549119patient 077, normal, homogenized [OPG study]3.8916813
GSM549133patient 032, cancer, homogenized [OPG study]3.8610713
GSM549139patient 042, cancer, homogenized [OPG study]3.8046611
GSM549099patient 107, normal, homogenized [OPG study]4.2001121
GSM549109patient 139, normal, homogenized [OPG study]3.9077513
GSM549110patient 046, normal, homogenized [OPG study]4.1370120
GSM549114patient 063, normal, homogenized [OPG study]3.9593816
GSM549122patient 082, normal, homogenized [OPG study]3.9093113
GSM549134patient 033, cancer, homogenized [OPG study]3.802611
GSM549136patient 036, cancer, homogenized [OPG study]3.8941414
GSM549140patient 044, cancer, homogenized [OPG study]3.65267
GSM549111patient 047, normal, homogenized [OPG study]4.111420
GSM549113patient 057, normal, homogenized [OPG study]4.0011317
GSM549132patient 031, cancer, homogenized [OPG study]3.8647413
GSM549137patient 038, cancer, homogenized [OPG study]3.662447
GSM549142patient 047, cancer, homogenized [OPG study]3.815599
GSM549100patient 110, normal, homogenized [OPG study]4.1344219
GSM549107patient 135, normal, homogenized [OPG study]4.0950319
GSM549115patient 068, normal, homogenized [OPG study]4.165622
GSM549116patient 072, normal, homogenized [OPG study]4.2952324
GSM549120patient 078, normal, homogenized [OPG study]3.985816
GSM549131patient 030, cancer, homogenized [OPG study]3.8223612
GSM549118patient 074, normal, homogenized [OPG study]3.9089813
GSM549129patient 027, cancer, homogenized [OPG study]3.7874410
GSM549123patient 088, normal, homogenized [OPG study]4.3133625
GSM549124patient 006, cancer, homogenized [OPG study]3.689037
GSM549126patient 015, cancer, homogenized [OPG study]3.7794210
GSM549128patient 025, cancer, homogenized [OPG study]3.530064
GSM549103patient 117, normal, homogenized [OPG study]3.99415
GSM549117patient 073, normal, homogenized [OPG study]4.1127519
GSM549138patient 041, cancer, homogenized [OPG study]3.708399
GSM549141patient 045, cancer, homogenized [OPG study]3.696639
GSM549130patient 028, cancer, homogenized [OPG study]3.8622912
GSM549101patient 111, normal, homogenized [OPG study]3.8920513
GSM549105patient 128, normal, homogenized [OPG study]4.0004216
GSM549106patient 134, normal, homogenized [OPG study]3.9118615
GSM549112patient 048, normal, homogenized [OPG study]4.1866421
GSM549125patient 011, cancer, homogenized [OPG study]3.679567
GSM549127patient 024, cancer, homogenized [OPG study]3.642747
GSM549135patient 035, cancer, homogenized [OPG study]5.1110543